Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl

Washington University School of Medicine · NCT06439992

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
60
US sites recruiting
1
Study start
November 7, 2023
Record last updated
June 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this research study is to determine the safety of a radiotracer 18F-Fluselenamyl using positron emission tomography (PET) imaging.

Being studied: 18F-Fluselenamyl

Conditions: Alzheimer Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Male or Female, any race
  • Age ≥ 18 years
  • Healthy volunteers or volunteers with Alzheimer's disease

Exclusion Criteria

  • Has hypersensitivity to 18F-Fluselenamyl or any of its excipients ;
  • Has hypersensitivity to 11C-PIB or any of its excipients ;
  • Incapable of providing written informed consent or lacking a legally authorized representative (LAR) to provide informed consent ;
  • Unwilling or unable to undergo PET scans tracer injections ;
  • Unwilling or unable to undergo MRI (Aim 2 and Aim 3)
  • Any condition that, in the Investigator's opinion, could increase the risk to the participant, limit the participant's ability to tolerate the research procedures, or interfere with the collection/analysis of the data (e.g., renal or liver failure, advanced cancer);
  • Women who are currently pregnant or breast-feeding;
  • Current or recent (within 12 months prior to screening) participation in research studies involving radioactive agents such that the total research-related radiation dose to the participant in any given year would exceed the limits set forth in the U.S. Code of Federal Regulations (CFR) Title 21 Section 361.1.

Recruiting US locations

  • Washington University School of Medicine

    St Louis, MO 63110

    Site contact: Jayashree Rajamanickam · 314 273 6140 · jayashree.r@wustl.edu

Study contacts (from the official record)

  • Jayashree Rajamanickam · 314 273 6140 · jayashree.r@wustl.edu
  • Kelley Jackson · kelleyj@wustl.edu
All neurology studies in Missouri →
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl (NCT06439992) | Bored Studies